PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-38.19%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-26.78%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-62.08%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-81.50%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-66.03%
Negative net income growth while 6617.T stands at 57.84%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-66.07%
Negative EPS growth while 6617.T is at 57.84%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-66.22%
Negative diluted EPS growth while 6617.T is at 57.84%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.03%
Slight or no buybacks while 6617.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
141.51%
Positive 10Y revenue/share CAGR while 6617.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
89.48%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
20.00%
3Y revenue/share CAGR above 1.5x 6617.T's 4.55%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.76%
Net income/share CAGR 1.25-1.5x 6617.T's 106.40%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
207.10%
5Y net income/share CAGR 1.25-1.5x 6617.T's 160.60%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
130.41%
Below 50% of 6617.T's 438.42%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
308.17%
10Y equity/share CAGR above 1.5x 6617.T's 11.47%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
53.44%
5Y equity/share CAGR above 1.5x 6617.T's 10.11%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.99%
3Y equity/share CAGR above 1.5x 6617.T's 10.69%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.10%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
9.51%
Inventory growth well above 6617.T's 14.51%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.40%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.44%
We have a declining book value while 6617.T shows 1.40%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.42%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-19.59%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-12.35%
We cut SG&A while 6617.T invests at 147.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.